CLINICAL_TRIALS
research
· 2026-03-31
Clinical Trial Update: Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy [Phase 3]
Summary
A Phase 3 clinical trial is evaluating the efficacy and safety of Suzetrigine for pain associated with diabetic peripheral neuropathy and is currently recruitin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 3 | Status: RECRUITING